Latest News for CNVVY
Convatec Group PLC (CNVVY) ConvaTec Group PLC, 4 Months Period Ending/ Trading Statement Call Transcript
British medical products maker Convatec on Thursday posted slower organic revenue growth for the first four months of 2026 and its CEO warned of higher costs in 2027 due to the Iran conflict, sending shares 8% lower.
Shares in ConvaTec Group PLC (LSE:CTEC) led the FTSE 100 fallers on Thursday, dropping almost 5% despite saying it had made a "good start" to the year and was on track to hit 2026 guidance. The maker of medical products for managing chronic conditions reported organic revenue growth of 4.8% in the first four months of 2026, excluding its InnovaMatrix wound-care product.
LONDON--(BUSINESS WIRE)--Convatec, a leading medical products and technology company focused on chronic condition management, takes to the stage to showcase the breadth, depth and momentum behind its Advanced Wound Care innovation pipeline at the European Wound Management Association (EWMA) 2026 conference in Bremen, Germany, from 6–8 May 2026. Convatec's industry-leading Advanced Wound Care innovation is supported…
🧮 Earnings Move Analyzer
Insider Trading
No insider trades found for CNVVY.
Senate Trading
No Senate trades found for CNVVY.
U.S. House Trading
No House trades found for CNVVY.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.